These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 307327
1. Post-hypoxic intention myoclonus treated with 5-hydroxy-tryptophan and an extracerebral decarboxylase inhibitor. Magnussen I, Dupont E, Engbaek F, de Fine Olivarius B. Acta Neurol Scand; 1978 Apr; 57(4):289-94. PubMed ID: 307327 [Abstract] [Full Text] [Related]
2. Letter: Treatment of post-anoxic intention myoclonus. Van Woert MH, Sethy VH. Lancet; 1974 Jun 22; 1(7869):1285. PubMed ID: 4134164 [No Abstract] [Full Text] [Related]
3. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa. Van Woert MH, Rosenbaum D, Howieson J, Bowers MB. N Engl J Med; 1977 Jan 13; 296(2):70-5. PubMed ID: 401457 [Abstract] [Full Text] [Related]
4. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486. Van Woert MH, Sethy VH. Neurology; 1975 Feb 13; 25(2):135-40. PubMed ID: 1078720 [Abstract] [Full Text] [Related]
5. Palatal myoclonus treated with 5-hydroxytryptophan and a decarboxylase-inhibitor. Magnussen I, Dupont E, Prange-Hansen A, de Fine Olivarius B. Acta Neurol Scand; 1977 Mar 13; 55(3):251-53. PubMed ID: 300537 [No Abstract] [Full Text] [Related]
6. Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam. Chadwick D, Hallett M, Harris R, Jenner P, Reynolds EH, Marsden CD. Brain; 1977 Sep 13; 100(3):455-87. PubMed ID: 412560 [Abstract] [Full Text] [Related]
11. Biochemistry and therapeutics of posthypoxic myoclonus. Van Woert MH, Rosenbaum D, Chung EY. Adv Neurol; 1986 Sep 13; 43():171-81. PubMed ID: 2418644 [No Abstract] [Full Text] [Related]
12. Improvement of action myoclonus by an administration of 5-hydroxytryptophan and carbidopa in a child with muscular subsarcolemmal hyperactivity. Nakano K, Hayakawa T, Shishikura K, Ohsawa M, Suzuki H, Fukuyama Y. Brain Dev; 1990 Sep 13; 12(5):516-20. PubMed ID: 2288384 [Abstract] [Full Text] [Related]
13. L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent. Growdon JH, Young RR, Shahani BT. Neurology; 1976 Dec 13; 26(12):1135-40. PubMed ID: 1086988 [Abstract] [Full Text] [Related]
14. L-5-hydroxytryptophan therapy in myoclonus. Van Woert MH, Rosenbaum D. Adv Neurol; 1979 Dec 13; 26():107-15. PubMed ID: 316273 [No Abstract] [Full Text] [Related]
15. Pathological findings in a case of hypoxic myoclonus treated with 5-hydroxytryptophan and a decarboxylase inhibitor. De Léan J, Richardson JC, Rewcastle NB. Adv Neurol; 1986 Dec 13; 43():215-23. PubMed ID: 2418647 [Abstract] [Full Text] [Related]
16. Fluoxetine in the treatment of intention myoclonus. Van Woert MH, Magnussen I, Rosenbaum D, Chung E. Clin Neuropharmacol; 1983 Mar 13; 6(1):49-54. PubMed ID: 6189599 [Abstract] [Full Text] [Related]
17. Further observations on the use of 5-hydroxytryptophan in a child with Lesch-Nyhan syndrome. Anders TF, Cann HM, Ciaranello RD, Barchas JD, Berger PA. Neuropadiatrie; 1978 May 13; 9(2):157-66. PubMed ID: 308621 [Abstract] [Full Text] [Related]
18. Serotonin and myoclonus. Van Woert MH, Jutkowitz R, Rosenbaum D, Bowers MB. Monogr Neural Sci; 1976 May 13; 3():71-80. PubMed ID: 790170 [Abstract] [Full Text] [Related]
19. [Utilization of levo-5-hydroxytryptophan in post-anoxic myoclonus]. Rascol A, Guiraud-Chaumeil B, Laboucarie J, Montastruc JL, El-Hage W. Therapie; 1978 May 13; 33(5):623-8. PubMed ID: 311085 [No Abstract] [Full Text] [Related]
20. Myoclonus and L-5-hydroxytryptophan (L-5HTP). Van Woert MH. Prog Clin Biol Res; 1983 May 13; 127():43-52. PubMed ID: 6351100 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]